HEALTH PROTECTION AGENCY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 3106
 
  
 
B05D PROCESSES FOR APPLYING LIQUIDS OR OTHER FLUENT MATERIALS TO SURFACES, IN GENERAL 384
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C07K PEPTIDES 1135
 
  
 
H05K PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS 1155

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2015/0010,580 ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINSMar 18, 14Jan 08, 15[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6743444 Method of making microencapsulated DNA for vaccination and gene therapyJul 03, 01Jun 01, 04[A61K]
6667294 Microencapsulated DNA for vaccination and gene therapyNov 12, 96Dec 23, 03[A61K, C12N]
6565777 Encapsulation of bioactive agentsMay 29, 02May 20, 03[B05D, B01J]
6406719 Encapsulation of bioactive agentsAug 03, 01Jun 18, 02[B05D, B01J]
6309569 Encapsulation of bioactive agentsMay 13, 99Oct 30, 01[B05D, B01J]
6270795 Method of making microencapsulated DNA for vaccination and gene therapyMay 15, 98Aug 07, 01[A61K, C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0092,519 COMPOSITIONS COMPRISING POLYSACCHARIDE CONJUGATES AND THEIR USE AS VACCINESAbandonedFeb 20, 08Apr 15, 10[A61K, A61P]
2010/0003,740 CHEMICALLY DEFINED CULTURE MEDIUM FOR NEISSERIAAbandonedMay 18, 07Jan 07, 10[C12N]
2009/0087,877 INFECTIVITY ASSAYAbandonedFeb 23, 07Apr 02, 09[C12Q, C12N]
2009/0060,901 DETOXIFICATION METHODAbandonedFeb 10, 06Mar 05, 09[A61K, A61P, C07K]
2008/0233,131 VaccineAbandonedSep 13, 05Sep 25, 08[A61K, A61P]
7384645 Outer membrane vesicles from gram negative bacteria and use as a vaccineExpiredDec 17, 02Jun 10, 08[]
2007/0248,626 Recombinant toxin fragmentsAbandonedDec 22, 06Oct 25, 07[A61K, C07K]
6984513 Anaerobe targeted enzyme-mediated prodrug therapyExpiredMay 31, 02Jan 10, 06[A01N, C12N]
2005/0208,608 Assay with reduced backgroundAbandonedFeb 25, 05Sep 22, 05[C12Q]
2005/0163,776 Treatment of tse infectionAbandonedMar 29, 05Jul 28, 05[A61K]
2005/0112,145 Anthrax antigenic compositionsAbandonedDec 15, 04May 26, 05[A61K]
2004/0265,328 Pathogenic and commensal vaccine antigensAbandonedJul 26, 04Dec 30, 04[A61K, C12Q, G01N]
2004/0110,269 Protection against mycobacterial infectionsAbandonedFeb 10, 04Jun 10, 04[C12N]
2004/0014,191 Nitroreductase enzymesAbandonedFeb 12, 03Jan 22, 04[C07H, C12P, C12N]
6660264 Treatment of intracellular infectionExpiredNov 20, 01Dec 09, 03[A61K, C12N]
2003/0186,848 Recombinant iron uptake proteinsAbandonedApr 24, 03Oct 02, 03[A61K, C07H, C12P, C12N, C07K]
5714364 Phenylalanine dehydrogenase productionExpiredMar 20, 96Feb 03, 98[C12P, C12N]
5059801 Radiation detectorExpiredAug 07, 89Oct 22, 91[G01J]
5055691 Radiation meterExpiredMay 31, 90Oct 08, 91[G01T]
4784589 Purification of pertussis antigensExpiredJan 20, 87Nov 15, 88[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.